particle&#32

3 trials

Sponsors

West China Hospital of Sichuan University, Shandong Cancer Hospital, Lanzhou University Second Hospital

Conditions

Craniocerebral injuryUrothelial Carcinomaprimary liver cancer

Early Phase 1

Clinical trial of abnormal prothrombin (PIVKA-II) assay kit (magnetic particle chemiluminescence method)

Active, not recruitingChiCTR2100048500

Shandong Cancer Hospitalprimary liver cancer

Start: 2021-08-01Updated: 2022-03-21

Unknown Phase

A clinical trial of tumor markers in the clinical application of urothelial carcinoma

Active, not recruitingChiCTR-DDD-17012810

Lanzhou University Second HospitalUrothelial Carcinoma

Start: 2017-10-16Updated: 2017-10-02

Application of GFAP and UCH-L1 in screening and prognosis of mild craniocerebral injury in children

Active, not recruitingChiCTR2000030955

West China Hospital of Sichuan UniversityCraniocerebral injury

Start: 2020-04-01Updated: 2020-03-23